Inhibikase Therapeutics, Inc. · NASDAQ:IKT
RA Capital Healthcare Fund LP reported 1 trade in Inhibikase Therapeutics, Inc. shares (Form 4)
Traded Jul 29, 2026 · Filed Jul 31, 2026
On Jul 29, 2026, RA Capital Healthcare Fund LP (10% owner) reported 1 trade in Inhibikase Therapeutics, Inc. shares, leaving 6,970,000 shares. Filed Jul 31, 2026 (Form 4).
- Shares
- 18,030,000 shares
- Holding after
- 6,970,000 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Common Stock | Other | 18,030,000 | 6,970,000 | Indirect |
Source
Related
- Inhibikase Therapeutics, Inc.
- RA Capital Healthcare Fund LP
- Inhibikase Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Aug 13, 2026
- Form 4 · Berman Dennis N · Jul 31, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Jul 31, 2026